Challenges Following CRS and HIPEC Surgery in Cancer Patients with Peritoneal Metastasis: a Comprehensive Review of Clinical Outcomes

Overview

Journal Front Surg

Specialty General Surgery

Date 2024 Dec 17

PMID 39687325

Authors

Mehdi Karimi

Niyousha Shirsalimi

Eshagh Sedighi

Affiliations

Soon will be listed here.

Abstract

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are a pair of relatively modern therapeutic surgical methods in advanced cancerous patients with peritoneal metastasis (PM). The goal of CRS + HIPEC is treatment or to improve survival outcomes, which are linked to high morbidity side effects and complications, even with their possible advantages. Surgical-related, chemotherapy-related, anesthetic-related, gastrointestinal, organs and systemic complications are the categories into which complications are separated according to frequency, risk factors, and effect on patient outcomes. In this narrative review of the literature, the side effects and complications of HIPEC + CRS in cancer patients with PM are examined. The present knowledge on the incidence, frequency, kinds, and risk factors of acute complications following CRS + HIPEC is summarized in this study. This review emphasizes the need for careful patient selection criteria, precise surgical technique, and thorough intraoperative care to reduce or manage these risks. Moreover, it highlights the need for interdisciplinary collaboration in treating these patients. This study aims to know these complications, improve clinical practice, and guide future studies to increase the safety and efficacy of CRS + HIPEC in treating metastatic colorectal cancer.

References

Duzgun O, Kalin M . Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients. J Int Med Res. 2019; 47(10):4911-4919. PMC: 6833411. DOI: 10.1177/0300060519872618. View

Ryu J, Koo C . Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Korean J Anesthesiol. 2021; 74(2):89-90. PMC: 8024208. DOI: 10.4097/kja.21099. View

Segura-Sampedro J, Craus-Miguel A, Gonzalez-Argente X, Morales-Soriano R . ASO Author Reflections: Diaphragmatic Resection Often Is Needed in CRS/HIPEC But Does Not Increase Respiratory Complications. Ann Surg Oncol. 2021; 28(8):4683-4684. DOI: 10.1245/s10434-020-09530-2. View

Casado-Adam A, Alderman R, Stuart O, Chang D, Sugarbaker P . Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Int J Surg Oncol. 2012; 2011:468698. PMC: 3263671. DOI: 10.1155/2011/468698. View

Kang H, Ma J, Su Y, Kang S, Feng B, Feng X . Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. Front Oncol. 2023; 13:1120499. PMC: 10073652. DOI: 10.3389/fonc.2023.1120499. View

Xia W, Geng Y, Hu W . Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer. Cancers (Basel). 2023; 15(23). PMC: 10705712. DOI: 10.3390/cancers15235641. View

Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T . Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol. 2020; 12(8):903-917. PMC: 7443840. DOI: 10.4251/wjgo.v12.i8.903. View

Roh S, Park S, Choi J, Lee J, Lee D, Hong C . Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis. Ann Coloproctol. 2020; 36(1):22-29. PMC: 7069674. DOI: 10.3393/ac.2019.04.30. View

Santullo F, Abatini C, Attalla El Halabieh M, Ferracci F, Lodoli C, Barberis L . The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis. Front Surg. 2022; 9:877970. PMC: 9157764. DOI: 10.3389/fsurg.2022.877970. View

10.

Tuttle T, Huang J, Kizy S, Altman A, Nalluri H, Marmor S . Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2019; 36(1):812-816. DOI: 10.1080/02656736.2019.1641634. View

11.

Sugarbaker P, Ronnett B, Archer A, Averbach A, Bland R, Chang D . Pseudomyxoma peritonei syndrome. Adv Surg. 1996; 30:233-80. View

12.

Gronau F, Feldbruegge L, Oberwittler F, Gonzalez-Moreno S, Villeneuve L, Eveno C . HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques. J Clin Med. 2022; 11(5). PMC: 8911234. DOI: 10.3390/jcm11051456. View

13.

Halkia E, Efstathiou E, Rogdakis A, Christakis C, Spiliotis J . Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis. J BUON. 2015; 20 Suppl 1:S60-3. View

14.

Mor E, Assaf D, Laks S, Benvenisti H, Ben-Yaacov A, Zohar N . The impact of gastrointestinal anastomotic leaks on survival of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. Am J Surg. 2021; 223(2):331-338. DOI: 10.1016/j.amjsurg.2021.03.061. View

15.

Dazza M, Schwarz L, Coget J, Frebourg N, Wood G, Huet E . Does Intraoperative Systematic Bacterial Sampling During Complete Cytoreductive Surgery (CRS) with Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) Influence Postoperative Treatment? A New Predictive Factor for Postoperative Abdominal.... World J Surg. 2016; 40(12):3035-3043. DOI: 10.1007/s00268-016-3635-6. View

16.

Fisher S, Rafeeq S, Hess K, Grotz T, Mansfield P, Royal R . Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). J Surg Oncol. 2017; 117(4):685-691. DOI: 10.1002/jso.24904. View

17.

Pintado M, Unzue I, Sanz R, Alonso M, Ortega M, Alvarez De Mon M . Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Clin Med. 2023; 12(13). PMC: 10342859. DOI: 10.3390/jcm12134323. View

18.

Aksamija G, Mulabdic A, Rasic I, Aksamija L . Evaluation of Risk Factors of Surgical Wound Dehiscence in Adults After Laparotomy. Med Arch. 2016; 70(5):369-372. PMC: 5136427. DOI: 10.5455/medarh.2016.70.369-372. View

19.

Feenstra T, Verberne C, Kok N, Aalbers A . Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer. Eur J Surg Oncol. 2022; 48(12):2460-2466. DOI: 10.1016/j.ejso.2022.05.018. View

20.

Macri A, Accarpio F, Arcoraci V, Casella F, Cian F, De Iaco P . Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study. Pleura Peritoneum. 2021; 6(1):21-30. PMC: 8223801. DOI: 10.1515/pp-2020-0139. View